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MUSCLE OXYGENATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE DURING 
WALKING WITH AND WITHOUT AN ANKLE FOOT ORTHOSIS
• PAD is caused by atherosclerotic plaques that limit blood flow to the
lower extremities1.
• Claudication, walking-induced pain in the legs, is the most common
manifestation of PAD2.
• The times of claudication pain onset and at which claudication pain
forces patients to stop walking are known as initial (ICT) and absolute
claudication times (ACT), respectively.
• Muscle oxygenation is significantly lower at rest, and it declines faster in
the calf muscles of patients with PAD compared to healthy controls3.
• An ankle foot orthosis (AFO) can improve muscle oxygen levels in
patients with PAD by absorbing and returning mechanical force, thus
decreasing calf muscle demand during walking.
• To measure the muscle oxygenation of the calf muscle in patients with
peripheral artery disease (PAD) during walking with and without an
ankle foot orthosis (AFO).
[5]
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Figure 1: The StO2 percentage at ICT and ACT for 
both NAF and AFO trials. * indicates statistically 
significant difference between NAF and AFO (p < 0.05).  
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• Patients were recruited through the clinic at the Nebraska-Western
Iowa Veterans Affairs Medical Center.
• A muscle oxygen monitor (PortaMon, Artinis Medical System) was
attached to patient’s gastrocnemius.
• Subjects performed the Gardner maximum walk test on a treadmill
(0.89 m/s (2.0 mph) that began at 0% grade and increased 2% grade
every two minutes).
• Subjects verbally indicated the onset of pain (ICT) and when they were
no longer able to walk (ACT).
• The subjects performed the protocol twice, once without AFO (NAF)
and once while wearing the AFO (AFO).
• The StO2 at ICT was 36.97%
higher, a significant increase
while using the AFO compared
to NAF (p = 0.016).
• Similarly, at ACT the StO2
significantly increased 30.19%
for AFO trial (p = 0.029).
• This suggests using the AFO
improves the oxygenated
hemoglobin delivery to working
muscle during exercise,
providing a mechanism for
increased walking distances
while using the AFO.
• Our results demonstrate that using the AFO significantly improved the muscle oxygenation
in calf muscle in patients with PAD.
• Future studies should examine how StO2 impacts physical activity, muscle activity, lower
extremity torque and power, and energy cost.
• This study was supported by NIH grants
(R01AG034995 and R01HD090333).
• Ottobock donated some of the AFOs used in
the study.
• Muscle oxygen saturation, StO2,
was recorded at ICT and ACT for
both AFO and NAF trials and
compared by a paired-sample t-
test (p < 0.05).
